0.026516 0.000000 0.000000 0.000000 0.026516 0.000000 0.000000 0.000000 0.014747 0.00000 0.00000 0.00000 Uson, I. Sheldrick, G.M. De La Fortelle, E. Bricogne, G. Di Marco, S. Priestle, J.P. Gruetter, M.G. Mittl, P.R.E. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 37.713 37.713 67.812 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking O4 S -2 96.063 SULFATE ION non-polymer C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure Fold.Des. FODEFH 1263 0969-2126 7 55 63 10.1016/S0969-2126(99)80009-4 10368273 The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitors. 1999 UK Structure STRUE6 2005 0969-2126 5 253 A New Structural Class of Serine Protease Inhibitors Revealed by the Structure of the Hirustasin-Kallikrein Complex 1997 UK Structure STRUE6 2005 0969-2126 5 585 Erratum. A New Structural Class of Serine Protease Inhibitors Revealed by the Structure of the Hirustasin-Kallikrein Complex 1997 US Protein Sci. PRCIEI 0795 0961-8368 6 109 Recombinant Hirustasin: Production in Yeast, Crystallization, and Interaction with Serine Proteases 1997 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 BENT CRYSTAL IMAGE PLATE 1996-11 MARRESEARCH GE(111) M x-ray 1 1.050 1.0 BW7B EMBL/DESY, Hamburg 1.050 SYNCHROTRON EMBL/DESY, HAMBURG BEAMLINE BW7B 5886.788 HIRUSTASIN 1 man polymer 96.063 SULFATE ION 2 syn non-polymer 18.015 water 52 nat water no no TQGNTCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAKASQ TQGNTCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAKASQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n medicinal leech Hirudo baker's yeast Saccharomyces sample 6421 Hirudo medicinalis 4932 Saccharomyces cerevisiae 1 2.0 40 TWO DIFFERENT INDEPENDENT METHODS WERE USED FOR STRUCTURE SOLUTION 5.45 pH 5.45 repository Initial release Version format compliance Version format compliance 1 0 1999-04-27 1 1 2008-03-24 1 2 2011-07-13 Y 1998-10-14 REL REL SO4 SULFATE ION HOH water SO4 100 2 SO4 SO4 100 A SO4 101 2 SO4 SO4 101 A HOH 1 3 HOH HOH 102 A HOH 2 3 HOH HOH 103 A HOH 3 3 HOH HOH 104 A HOH 4 3 HOH HOH 105 A HOH 5 3 HOH HOH 106 A HOH 6 3 HOH HOH 107 A HOH 7 3 HOH HOH 108 A HOH 8 3 HOH HOH 109 A HOH 9 3 HOH HOH 110 A HOH 10 3 HOH HOH 111 A HOH 11 3 HOH HOH 112 A HOH 12 3 HOH HOH 113 A HOH 13 3 HOH HOH 114 A HOH 14 3 HOH HOH 115 A HOH 15 3 HOH HOH 116 A HOH 16 3 HOH HOH 117 A HOH 17 3 HOH HOH 118 A HOH 18 3 HOH HOH 119 A HOH 19 3 HOH HOH 120 A HOH 20 3 HOH HOH 121 A HOH 21 3 HOH HOH 122 A HOH 22 3 HOH HOH 123 A HOH 23 3 HOH HOH 124 A HOH 24 3 HOH HOH 125 A HOH 25 3 HOH HOH 126 A HOH 26 3 HOH HOH 127 A HOH 27 3 HOH HOH 128 A HOH 28 3 HOH HOH 129 A HOH 29 3 HOH HOH 130 A HOH 30 3 HOH HOH 131 A HOH 31 3 HOH HOH 132 A HOH 32 3 HOH HOH 133 A HOH 33 3 HOH HOH 134 A HOH 34 3 HOH HOH 135 A HOH 35 3 HOH HOH 136 A HOH 36 3 HOH HOH 137 A HOH 37 3 HOH HOH 138 A HOH 38 3 HOH HOH 139 A HOH 39 3 HOH HOH 140 A HOH 40 3 HOH HOH 141 A HOH 41 3 HOH HOH 142 A HOH 42 3 HOH HOH 143 A HOH 43 3 HOH HOH 144 A HOH 44 3 HOH HOH 145 A HOH 45 3 HOH HOH 146 A HOH 46 3 HOH HOH 147 A HOH 47 3 HOH HOH 148 A HOH 48 3 HOH HOH 149 A HOH 49 3 HOH HOH 150 A HOH 50 3 HOH HOH 151 A HOH 51 3 HOH HOH 152 A HOH 52 3 HOH HOH 153 A n 1 1 A n 2 2 A GLY 3 n 3 GLY 3 A ASN 4 n 4 ASN 4 A THR 5 n 5 THR 5 A CYS 6 n 6 CYS 6 A GLY 7 n 7 GLY 7 A GLY 8 n 8 GLY 8 A GLU 9 n 9 GLU 9 A THR 10 n 10 THR 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A ALA 13 n 13 ALA 13 A ALA 14 n 14 ALA 14 A GLN 15 n 15 GLN 15 A VAL 16 n 16 VAL 16 A CYS 17 n 17 CYS 17 A LEU 18 n 18 LEU 18 A LYS 19 n 19 LYS 19 A GLY 20 n 20 GLY 20 A LYS 21 n 21 LYS 21 A CYS 22 n 22 CYS 22 A VAL 23 n 23 VAL 23 A CYS 24 n 24 CYS 24 A ASN 25 n 25 ASN 25 A GLU 26 n 26 GLU 26 A VAL 27 n 27 VAL 27 A HIS 28 n 28 HIS 28 A CYS 29 n 29 CYS 29 A ARG 30 n 30 ARG 30 A ILE 31 n 31 ILE 31 A ARG 32 n 32 ARG 32 A CYS 33 n 33 CYS 33 A LYS 34 n 34 LYS 34 A TYR 35 n 35 TYR 35 A GLY 36 n 36 GLY 36 A LEU 37 n 37 LEU 37 A LYS 38 n 38 LYS 38 A LYS 39 n 39 LYS 39 A ASP 40 n 40 ASP 40 A GLU 41 n 41 GLU 41 A ASN 42 n 42 ASN 42 A GLY 43 n 43 GLY 43 A CYS 44 n 44 CYS 44 A GLU 45 n 45 GLU 45 A TYR 46 n 46 TYR 46 A PRO 47 n 47 PRO 47 A CYS 48 n 48 CYS 48 A SER 49 n 49 SER 49 A CYS 50 n 50 CYS 50 A ALA 51 n 51 ALA 51 A LYS 52 n 52 LYS 52 A ALA 53 n 53 ALA 53 A n 54 54 A n 55 55 A 0.1286 0.1803 0.127 0.1794 0.1772 0.2254 522 792 5.1 5.0 10289 author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 16 A O VAL 16 A N VAL 23 A N VAL 23 1 A HOH 130 D HOH 1 A CD LYS 21 A CD LYS 21 1 Y 1 A CE LYS 21 A CE LYS 21 1 Y 1 A NZ LYS 21 A NZ LYS 21 1 Y 1 A THR 1 A THR 1 1 Y 1 A GLN 2 A GLN 2 1 Y 1 A SER 54 A SER 54 1 Y 1 A GLN 55 A GLN 55 1 Y 1 17.98 2.70 114.20 132.18 A A A CB CG CD GLU GLU GLU 9 9 9 B B N 1 13.23 2.20 113.40 126.63 A A A CA CB CG GLU GLU GLU 26 26 26 A N 1 12.05 1.40 123.60 135.65 A A A CD NE CZ ARG ARG ARG 32 32 32 N 1 -11.71 1.20 123.30 111.59 A A A OE1 CD OE2 GLU GLU GLU 45 45 45 A A A N 1 A GLU 45 -106.16 62.60 ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY 2% 0.2254 0.1803 0.1794 1.20 25.2 4045 792 15894 4895 5.0 99.2 RANDOM 1 FREE R 0.0 AB INITIO ENGH AND HUBER MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 5 342.00 417.02 1.20 25.2 52 449 10 0 387 0.014 0.036 0.000 0.029 0.140 0.120 0.042 0.004 0.097 0.096 1.2 25.2 1BX7 15928 0.0 0.043 1 15.0 2.4 99.4 0.376 1.20 1.25 1.61 1.8 98.1 data collection MARXDS data reduction MARSCALE model building SHELXL-97 refinement SHELXL-97 data reduction MARXDS data scaling MARSCALE phasing SHELXL-97 HIRUSTASIN HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.2 ANGSTROMS 1 N N 2 N N 2 N N 3 N N disulf 2.041 A CYS 6 A SG CYS 6 1_555 A CYS 17 A SG CYS 17 1_555 disulf 2.026 A CYS 11 A SG CYS 11 1_555 A CYS 22 A SG CYS 22 1_555 disulf 2.048 A CYS 24 A SG CYS 24 1_555 A CYS 44 A SG CYS 44 1_555 disulf 2.027 A CYS 29 A SG CYS 29 1_555 A CYS 48 A SG CYS 48 1_555 disulf 2.044 A CYS 33 A SG CYS 33 1_555 A CYS 50 A SG CYS 50 1_555 ANTI-COAGULANT ANTI-COAGULANT, PEPTIDIC INHIBITORS, CONFORMATIONAL FLEXIBILITY, SERINE PROTEASE INHIBITOR A TYR 46 A TYR 46 1 A PRO 47 A PRO 47 -9.16 ANTA_HIRME UNP 1 1 P80302 TQGNTCGGETCSAAQVCLKGKCVCNEVHCRIRCKYGLKKDENGCEYPCSCAKASQ 1 55 1BX7 1 55 P80302 A 1 1 55 2 anti-parallel A GLN 15 A GLN 15 A LEU 18 A LEU 18 A LYS 21 A LYS 21 A CYS 24 A CYS 24 BINDING SITE FOR RESIDUE SO4 A 100 Software 6 BINDING SITE FOR RESIDUE SO4 A 101 Software 5 A ARG 30 A ARG 30 6 6_454 A LYS 38 A LYS 38 6 1_555 A ALA 51 A ALA 51 6 1_555 A LYS 52 A LYS 52 6 1_555 A ALA 53 A ALA 53 6 1_555 A HOH 112 D HOH 6 1_555 A HIS 28 A HIS 28 5 3_634 A ARG 30 A ARG 30 5 6_454 A LYS 38 A LYS 38 5 1_555 A LYS 52 A LYS 52 5 1_555 A HOH 139 D HOH 5 3_634 96 P 43 21 2